Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study
Condition: Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma Intervention: Radiation: intensity-modulated radiotherapy (IMRT) Sponsor: National Taiwan University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Intensity-Modulated Radiation Therapy | Lymphoma | Primary CNS Lymphoma | Research | Revlimid | Study